These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 17227804)

  • 1. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
    Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
    Tessonnier L; Sebag F; Ghander C; De Micco C; Reynaud R; Palazzo FF; Conte-Devolx B; Henry JF; Mundler O; Taïeb D
    J Clin Endocrinol Metab; 2010 Jan; 95(1):303-7. PubMed ID: 19915018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDOPA PET/CT imaging of insulinoma revisited.
    Imperiale A; Sebag F; Vix M; Castinetti F; Kessler L; Moreau F; Bachellier P; Guillet B; Namer IJ; Mundler O; Taïeb D
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):409-18. PubMed ID: 25367749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography.
    Kauhanen S; Seppänen M; Nuutila P
    J Clin Oncol; 2008 Nov; 26(32):5307-8; author reply 5308-9. PubMed ID: 18854556
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
    Imperiale A; Bahougne T; Goichot B; Bachellier P; Taïeb D; Namer IJ
    Clin Nucl Med; 2015 Aug; 40(8):682-4. PubMed ID: 25549347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Feasibility of domestic (18)F-DOPA PET/CT scanning in the differential diagnosis of pancreatic lesions in children with hyperinsulinemic hypoglycemia].
    Zhang MY; Ge JJ; Pei Z; Dong KR; Chen L; Wang X; Zhang ZW; Li XJ; Xi L; Cheng RQ; Lu GP; Guan YH; Luo FH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):785-789. PubMed ID: 29050119
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of
    Imperiale A; Boursier C; Sahakian N; Ouvrard E; Chevalier E; Sebag F; Addeo P; Taïeb D
    J Nucl Med; 2022 Mar; 63(3):384-388. PubMed ID: 34272321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
    Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early
    Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
    Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
    Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
    Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F
    J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
    de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
    J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
    J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Tuzcu SA; Pekkolay Z; Kılınç F; Tuzcu AK
    J Nucl Med Technol; 2017 Sep; 45(3):198-200. PubMed ID: 28798227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
    Ambrosini V; Tomassetti P; Rubello D; Campana D; Nanni C; Castellucci P; Farsad M; Montini G; Al-Nahhas A; Franchi R; Fanti S
    Nucl Med Commun; 2007 Jun; 28(6):473-7. PubMed ID: 17460538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of
    Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Value of
    Nakuz TS; Berger E; El-Rabadi K; Wadsak W; Haug A; Hacker M; Karanikas G
    Anticancer Res; 2018 Jan; 38(1):353-358. PubMed ID: 29277794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.